Quantification of protein markers monitoring the pre-analytical effect of blood storage time before plasma isolation using 15N metabolically labeled recombinant proteins
- Quantification of protein markers monitoring the pre-analytical effect of blood storage time before plasma isolation using 15N metabolically labeled recombinant proteins
- 이철주; 안희성; 정현교; 박성준; 우세준
- Issue Date
- Journal of mass spectrometry : JMS
- VOL 53, NO 12-1197
- In the hospital, blood samples are collected to monitor patients' health states, and thus various protein‐ based clinical methods have been developed. However, some proteins are found to change in abundances during the process of blood collection and storage. In order to account such pre‐ analytical effects, we performed liquid chromatography multiple reaction monitoring mass spectrometry (LC‐ MRM‐ MS) on 15 selected proteins in plasma samples prepared by varying storage time and temperature of whole blood prior to plasma isolation. Two cytosolic proteins, profilin‐ 1 (PFN1) and thymosin beta‐ 4 (TMSB4X), were absolutely quantified using 15N‐ labeled recombinant proteins spiked externally. The other 13 proteins were quantified in a relative way compared with the two reference proteins. Triplicated LC‐ MS measurements showed that the median CV of MRM peak areas was 5.7%. The amounts of PFN1 and TMSB4X increased rapidly depending on the storage time between blood collection and plasma preparation. It indicates the leakage of cellular components into the plasma fraction. Relative quantification further revealed that five proteins including PFN1, S10A8, S10A9, S10A11, and TMSB4X showed significant difference (P < 0.05). We further monitored PFN1 and TMSB4X on 40 samples collected for protein diagnostics under a typical clinical study condition. Compared with the plasma samples prepared within a day, the level of both PFN1 and TMSB4X increased in the plasma samples prepared from the blood collected the day before and kept overnight at 4°C (0.51 to 3.11 μg/mL for PFN1 and 0.98 to 5.36 μg/mL for TMSB4X in average). Our result suggests an effort of assuring plasma quality for accurate protein‐ based diagnosis or biomarker discovery and validation.
- Appears in Collections:
- KIST Publication > Article
- Files in This Item:
There are no files associated with this item.
- RIS (EndNote)
- XLS (Excel)
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.